FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placeboContinue Reading
Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placeboContinue Reading
MONDAY, March 31, 2025 (HealthDay News) — A top vaccine official at the U.S. Food and Drug Administration (FDA) is stepping down, warning that vaccine misinformation is coloring the country’s top health decisions. Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said he will resignContinue Reading
Medication approved for uUTIs in women and pediatric patients aged 12 years and olderContinue Reading
TUESDAY, March 25, 2025 (HealthDay News) — Statins are very cheap and highly effective cholesterol-lowering drugs — but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, accordingContinue Reading
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn diseaseContinue Reading
MONDAY, March 24, 2025 (HealthDay News) — A fake web page designed to look like the U.S. Centers for Disease Control and Prevention’s (CDC) vaccine safety site has been taken down on orders from health secretary Robert F. Kennedy Jr. The site was linked to Children’s Health Defense, an anti-vaccineContinue Reading
MONDAY, March 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to treat transthyretin amyloid cardiomyopathy (ATTR-CM). ATTR-CM isContinue Reading
THURSDAY, March 13, 2025 (HealthDay News) — A growing measles outbreak has led to 222 reported cases across Texas, New Mexico and Oklahoma in 2025, with health officials urging more people to get vaccinated. During an interview with Fox News, U.S. Health and Human Services (HHS) Secretary Robert F. KennedyContinue Reading
TUESDAY, March 11, 2025 (HealthDay News) — The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, according to an email obtained by The Washington Post. The message — sent Monday by Michelle Bulls, director ofContinue Reading
MONDAY, March 10, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) is preparing to study whether vaccines are linked to autism — despite overwhelming scientific evidence showing no connection. The study request came from Trump administration officials, according to sources familiar with the plan. BothContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.